Fintel reports that on April 17, 2025, BMO Capital downgraded their outlook for Beacon Roofing Supply (NasdaqGS:BECN) from ...

NEW YORK (Reuters) - BMO Capital on Wednesday cut its year-end 2025 S&P 500 target by 9% to 6,100 from the prior 6,700, citing the speed and severity of the recent selloff. In a note to clients ...

BMO Capital downgraded Novo Nordisk (NVO) to Market Perform from Outperform with a price target of $64, down from $105. The company’s obesity ...

Fintel reports that on March 31, 2025, BMO Capital downgraded their outlook for United States Steel (SNSE:X) from Outperform to Market Perform. There are 927 funds or institutions reporting ...

BMO Capital raised the firm’s price target on Azek (AZEK) to $57 from $54 and keeps a Market Perform rating on the shares. The company’s acquisition by James Hardie (JHX) is very good from an ...

Fintel reports that on April 7, 2025, BMO Capital upgraded their outlook for Saia (NasdaqGS:SAIA) from Market Perform to Outperform. As of April 2, 2025, the average one-year price target for Saia ...

BMO Capital Markets downgraded Novo Nordisk (NYSE:NVO) to “Market Perform” from “Outperform” and cut its price target to $64, saying the Danish drugmaker’s early lead in the obesity drug market is ...

Company targeting US$10-15 million of new equity in the brokered private placement offering led by BMO Capital Markets, CIBC Capital Markets and Red Cloud Securities Inc. and including National Bank.